Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs

@article{Manski2021StatisticalDP,
  title={Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs},
  author={Charles F. Manski and Aleksey Tetenov},
  journal={Value in Health},
  year={2021},
  volume={24},
  pages={641 - 647}
}
Objectives Researchers studying treatment of coronavirus disease 2019 (COVID-19) have reported findings of randomized trials comparing standard care with care augmented by experimental drugs. Many trials have small sample sizes, so estimates of treatment effects are imprecise. Hence, clinicians may find it difficult to decide when to treat patients with experimental drugs. A conventional practice when comparing standard care and an innovation is to choose… Expand
3 Citations

Figures and Tables from this paper

Who should get vaccinated? Individualized allocation of vaccines over SIR network
  • T. Kitagawa, Guanyi Wang
  • Economics
  • Journal of Econometrics
  • 2021
How to allocate vaccines over heterogeneous individuals is one of the important policy decisions in pandemic times. This paper develops a procedure to estimate an individualized vaccine allocationExpand
Who should get vaccinated? Individualized allocation of vaccines over SIR network
TLDR
This paper develops a procedure to estimate an individualized vaccine allocation policy under limited supply, exploiting social network data containing individual demographic characteristics and health status, based on a Heterogeneous-Interacted-SIR network model. Expand

References

SHOWING 1-10 OF 22 REFERENCES
Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II
TLDR
A refined version of that analysis applicable to trials comparing aggressive treatment of patients with surveillance, based on a trial comparing nodal observation and lymph node dissection when treating patients with cutaneous melanoma, concludes that assigning 244 patients to each option would yield findings that enable suitably near-optimal treatment choice. Expand
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
TLDR
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit. Expand
Clinical trial design enabling {\epsilon}-optimal treatment rules
Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesians have argued that trials should be designed toExpand
Bayesian Statistics and the Efficiency and Ethics of Clinical Trials
The Bayesian approach is being used increasingly in medical research. The flexibility of the Bayesian approach allows for building designs of clinical trials that have good properties of any desiredExpand
An economic approach to clinical trial design and research priority-setting.
TLDR
A decision-analytic approach to trial design is presented which takes explicit account of the costs of sampling, the benefits of sample information and the decision rules of cost-effectiveness analysis and provides practical tools to establish the optimal allocation of resources between areas of clinical research or between service provision and research. Expand
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
  • K. Claxton
  • Economics, Medicine
  • Journal of health economics
  • 1999
TLDR
It is argued here that rules of inference are arbitrary and entirely irrelevant to the decisions which clinical and economic evaluations claim to inform and a framework for decision making and establishing the value of additional information is presented which is consistent with the decision rules in CEA. Expand
Decision analysis and bioequivalence trials
It is argued that the determination of bioequivalence involves a decision, and is not purely a problem of inference. A coherent method of decision-making is examined in detail for a simple trial ofExpand
Reasonable patient care under uncertainty.
  • C. Manski
  • Medicine, Psychology
  • Health economics
  • 2018
TLDR
How limited ability to predict illness and treatment response may affect the welfare achieved in patient care is discussed and basic decision theory is applied to suggest reasonable decision criteria with well-understood welfare properties. Expand
Statistical treatment rules for heterogeneous populations
An important objective of empirical research on treatment response is to provide decision makers with information useful in choosing treatments. This paper studies minimax-regret treatment choiceExpand
Incorporating Bayesian Ideas into Health-Care Evaluation
We argue that the Bayesian approach is best seen as providing additional tools for those carrying out health-care evaluations, rather than replacing their traditional methods. A distinction is madeExpand
...
1
2
3
...